Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Pioglitazone-Metformin Combination Treatment for High Risk Oral Preneoplasia	Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Site, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Stomatognathic Diseases, leukoplakia, mouth disorder, neoplasm, oral mucosa leukoplakia, precancerous condition	Recruiting	Phase 2	2026-07-29		NCT05727761

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
University of Minnesota	344

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
HealthPartners	Saint Paul	United States	2
University of Minnesota	Minneapolis	United States	325

Clinical trials